Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
about
From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myelomaMaintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma.Multiple myeloma: managing a complex blood cancer.
P2860
Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Renal complications in multipl ...... dation Nurse Leadership Board.
@ast
Renal complications in multipl ...... dation Nurse Leadership Board.
@en
type
label
Renal complications in multipl ...... dation Nurse Leadership Board.
@ast
Renal complications in multipl ...... dation Nurse Leadership Board.
@en
prefLabel
Renal complications in multipl ...... dation Nurse Leadership Board.
@ast
Renal complications in multipl ...... dation Nurse Leadership Board.
@en
P2093
P2860
P356
P1476
Renal complications in multipl ...... ndation Nurse Leadership Board
@en
P2093
Beth M Faiman
Jacy Spong
Patricia Mangan
The International Myeloma Foundation Nurse Leadership Board
P2860
P356
10.1188/11.CJON.S1.66-76
P478
P577
2011-08-01T00:00:00Z